Share this article:
New book examines Mild Traumatic Brain Injury
Mild traumatic brain injury (mTBI) is a disorder that has gained increasing attention in the last several years because of its impact on professional sports and U.S. Service members returning after deployment overseas. In fact, mTBI occurs in all segments of the population and has a significant impact on individuals over a wide range of ages who are injured in a variety of settings. In simplest terms, mTBI is just as the words describe, a brain injury that is mild and caused by trauma. It is essentially synonymous with a concussion. However, in modern usage the term mTBI has taken on more significance and has come to signify not only the injury but all of the associated signs and symptoms both physical, emotional, and psychosocial. Much of this new notoriety stems from the fact that the nosology of mTBI is ill defined and, despite a significant amount of study, many of the particulars about the disorder are poorly understood.
The goal of Neurosensory Disorders in Mild Traumatic Brain Injury edited by Michael Hoffer, University of Miami Miller School of Medicine, and Carey Balaban (University of Pittsburgh) is to explore this injury pattern and describe some of the more important findings in the basic sconce, clinical science, and clinical management of mTBI. The book features and international team of subject matter expert and will be a valuable resource for all of those who study and treat this disorder.
About the book
- Provides a comprehensive examination of the neurosensory issues associated with mild Traumatic Brain Injury and concussion
- Brings together both the basic science work and the clinical work in mTBI into a single volume
- Helps clinicians understand the best diagnosis and treatment paths and puts current research into perspective for researchers
The book is available now on ScienceDirect. Prefer your own copy? Order on the Elsevier store. Enter code STC319 at the checkout to save up to 30% discount.
The scientific study of the nervous system is entering a new golden age. Researchers and clinicians continue to advance the treatment of conditions such as Alzheimer’s syndrome, Parkinson’s disease, epilepsy, and traumatic brain injury. Public initiatives like the federal Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) program in the United States, announced in April 2013, ensure that funding and resources will continue to be applied to this rapidly growing field. Elsevier’s journals, books, eBooks, online references, and tools are respected around the world for everything from physiology and pathology to behavioral genetics and nerve repair. Our publications are a gateway to the latest advancements in neuroscience research and leading-edge data for professionals, students, and academics alike.